Search ( 33811 results )
(Updated on )
HIV Surveillance Among Allogeneic Blood Donors. The Fight Against HIV/AIDS and Sexually Transmitted Infections in France: 10 Years of Surveillance, 1996–2005
- A decline in HIV prevalence among blood donors through 1998, followed by stabilization at around 0.5 per 10,000 new donors between 1998 and 2005. - Stability in HIV incidence among...
- conference presentation
(Updated on )
Homosexuals and Blood Donation Exclusion: Impact on the Residual Risk of HIV Transmission Through Transfusion. Public Health Watch Conference, Paris, November 26–28, 2008
- report/summary
(Updated on )
Quantitative Estimation of the Risk of Blood Donation Contamination by Infectious Agents. Working Group of Afssaps, EFS, INTS, and InVS
The presence of asymptomatic shedding of certain infectious agents in the bloodstream poses a risk of transmission of these agents during blood transfusions. While this risk is currently...
- article
(Updated on )
Screening for markers of transfusion-transmissible infections in blood donations collected in France from 1996 to 1998
From 1996 to 1998, a decline in the rates of donations testing positive for the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg) was...
(Updated on )
Epidemiological surveillance of allogeneic blood donors in France between 2001 and 2003. National Surveillance of Infectious Diseases, 2001–2003
Key points: - Prevalence rates remained stable over the 2001–2003 period: 0.60 per 104 new donors for HIV, 8.0 per 104 for HCV, 1.8 per 104 for HBsAg, and 0.56 per 104 for HTLV. -...
- article
(Updated on )
Evaluation of Pre- and Post-Transfusion Serological Screening in France in 2001
HIV and HCV screening for recipients of labile blood products was recommended in France in 1996 by a ministerial circular. Conducted prior to transfusion and within the following four...
- article
(Updated on )
Prevalence of hepatitis B and C viruses, HIV, and HTLV among candidates for scheduled autologous transfusions in France, 1993–2000
Epidemiological surveillance of candidates for autologous transfusion was established in France in 1993. The number of candidates increased steadily between 1993 and 1997 and then...
- article
(Updated on )
Application of molecular biology to blood transfusion safety: genomic viral screening
Viral genomic screening (VGS) for HIV-1 and HCV was introduced in France on July 1, 2001, with the aim of enhancing transfusion safety by reducing the residual risk posed by the...
- article
(Updated on )
Residual risk of HIV, HCV, and HBV transmission through blood transfusion in France between 1992 and 2002 and the impact of viral genomic testing
Changes in the residual viral risk associated with labile blood products are an important indicator for assessing the impact of measures aimed at improving viral safety in blood...
